Capillary Tech.

Q1 FY27IT - Software

Capillary Tech. Q1 FY27 earnings call: Revenue & Margins

Q1 FY27 earnings call: what management guided on revenue, margins and order book.

Price₹510

Market cap₹4.0K Cr

P/E78.0

Updated25 Aug 2026

Read4 min read

What the Q1 FY27 call signalled

2 of 3 strong

RevenueGood growth

MarginMargins steady

CapexCapex planned

The short version

Capillary Technologies expects to exceed their revenue guidance of INR1,065 crores and INR172 crores EBITDA but is not revising guidance yet. Capillary Technologies expects to exceed its revenue guidance of INR1,065 crores and INR172 crores EBITDA but is not revising guidance yet (Page 24).

From Capillary Tech.'s Q1 FY27 earnings-call transcript · updated 25 Aug 2026.

Revenue & Sales Performance

Good growth

Capillary Technologies expects to exceed their revenue guidance of INR1,065 crores and INR172 crores EBITDA but is not revising guidance yet.
New Annual Contract Value (ACV) grew about 75% YoY, indicating strong momentum in new sales across US, Europe, and Asia.
Organic growth guidance for FY27 is around 17%-23%, with inorganic growth supplementing this.
SessionM acquisition adds to revenue with server cost efficiencies improving margins; migration expected over 2-3 years.
Net Retention Rate (NRR) expansion and upselling new AI products contribute to higher revenues and margins.
Company targets combined 15%-20% organic growth with ongoing inorganic acquisitions as a sales motion.

2 more points management made on revenue & sales performance

Profitability & Margins

Capillary Technologies expects to exceed its revenue guidance of INR1,065 crores and INR172 crores EBITDA but is not revising guidance yet (Page 24).
Organic growth is projected at about 17% full-year, factoring in currency impact (~6%) (Page 18).
New ACV is seeing strong momentum with potential to deliver 30-40% more new ACV than last year (Page 23).
SessionM acquisition is expected to improve margins from break-even to ~15% EBITDA in one year, and 35-40% over two years through operational efficiencies (Page 23).
The company maintains a Rule of 40 metric of about 60 (growth + EBITDA%), with organic EBITDA margins over 20% and overall adjusted EBITDA ~17% (Page 8).

2 more points management made on profitability & margins

See what Capillary Tech. said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Capex planned

The provided pages from the Capillary Technologies India Limited Q1 FY27 earnings call transcript do not explicitly mention any current or future capital expenditure (capex), capital investment, or strategic investment plans. However, some relevant points inferred include: - Focus on M&A strategy: The company continues to pursue inorganic growth by acquiring businesses, primarily to add long-term contracts and migrate customers to Capillary’s tech platform. - Investments in technology: Significant investment in AI for faster and more efficient migration of acquired customers to Capillary’s platform.

- Product and platform enhancements: Continuous investment to maintain a leadership position and stay at least a year ahead of competitors in product quality. - No direct mention of specific capex spend or strategic capital outlay figures or forecasts in the provided pages. If you need more detailed or specific insights on capex or strategic investments, those might appear elsewhere in the full report.

2 more points management made on capital expenditure plans

Top-ranked in IT - Software

Ranked on what management guided this quarter

5x potential

1Workmates Core2cloud Solution Ltd₹536 Cr

Rev 1Mar 1

2Virtual Galaxy₹361 Cr

Rev 1Mar 3

3₹194 Cr

Rev 2Mar 1

4₹140 Cr

Rev 2Mar 1

5₹2.0K Cr

Rev 2Mar 2

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

There is no explicit mention of any current or planned fundraising through debt or equity in the provided transcript.
Aneesh Reddy discussed acquisitions and organic growth but did not reference any fundraising activities.
The company focuses on disciplined M&A at attractive prices and strong organic growth, implying internal funding for expansion.

2 more points management made on fundraising & capital structure

See what Capillary Tech. said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The ACV (Annual Contract Value) reported was INR 92 crores, up from INR 53 crores previously, representing about 80% growth on a trailing 12-month basis.
Average deal cycles are approximately 9 months, so quarter-to-quarter comparisons are less meaningful.
There is strong momentum in new sales across the US, Europe, and Asia.
Expecting at least 30%-40% more new ACV than last year, though unlikely to hit 75% growth for the full year.
INR 20 crores from INR 390 crores of revenue has the potential to deliver an incremental INR 120-130 crores as migrations and upgrades happen.

2 more points management made on order book & pipeline

Capillary Tech. — Quarterly revenue & net profit

Revenue Net profit

Dec 2024

Mar 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹191 Cr, net profit ₹43 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What Capillary Technologies India Ltd's management said in earlier quarters

Others in IT - Software this season

Workmates Core2cloud Solution Ltd (Q1 FY27)
FY26 total revenue: ₹143 Cr (Page 10) . Key concall takeaways from Workmates Core2cloud Solution Ltd's Q1 FY27 earnings call — and how it ranks against sector…
Softtech Engineers Ltd (Q1 FY27)
Revenue from Operations (Standalone) for Q1 FY27: INR 3,222.02 Lakhs, up 25.0% YoY from INR 2,578.58 Lakhs in Q1 FY26 . Key concall takeaways from Softtech…
Tanla Platforms Ltd (Q1 FY27)
Revenue for Q1 FY27: ₹12,264 Mn, up 17.8% YoY and 4.1% QoQ (Pages 3, 7, 21). Key concall takeaways from Tanla Platforms Ltd's Q1 FY27 earnings call — and how…
ASM Technologies Ltd (Q1 FY27)
Revenue from Operations for Q1 FY27: ₹198.8 Cr, up 62% YoY from ₹122.9 Cr in Q1 FY26 (Page 8). Key concall takeaways from ASM Technologies Ltd's Q1 FY27…

Compare:vs Tata Consultancy Services Ltd vs Infosys Ltd vs HCL Technologies Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Capillary Tech. Q1 FY27 results?

What is Capillary Tech. share price analysis?

Capillary Tech. currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 78.0 with a market cap of ₹3,998 Cr. Investors should review the full earnings analysis for detailed insights.

Is Capillary Tech. planning capital expenditure?

Keep Capillary Tech. on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.